Abstract
Recombinant antibody technology is opening new perspectives for the development of novel therapeutic and diagnostic agents. In this review we focus on advances in the generation of both genetically engineered humanized and fully human monoclonal antibodies. Methods for their production in different expression systems are also discussed.
Similar content being viewed by others
References
Riethmüller, G., Schneider Gadicke, E., and Johnson, J. P. (1993) Monoclonal antibodies in cancer therapy. Curr. Opin. Immunol. 5, 732–739.
Jaffers, G. J., Fuller, T. C., Cosimi, A. B., Russell, P. S., Winn, H. J., and Colvin, R. B. (1986) Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation 41, 572–578.
Khazaeli, M. B., Conry, R. M., and LoBuglio, A. F. (1994) Human immune response to monoclonal antibodies. J. Immunotherapy 15, 42–52.
James, K. (1994) Human monoclonal antibody technology, in Handbook of Experimental Pharmacology, Vol. 113: The Pharmacology of Monoclonal Antibodies (Rosenberg, M., and Moore, G. P., eds.), Springer-Verlag, Berlin, Heidelberg, pp. 3–22.
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., and Whitlow, M. (1988) Single-chain antigen-binding proteins. Science 242, 423–426.
Huston, J. S., Levinson, D., Mudgett Hunter, M., Tai, M. S., Novotny, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., Crea, R., and Oppermann, H. (1988) Protein engineering of anti-body binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85, 5879–5883.
Borrebaeck, C. A., Danielsson, L., and Moller, S. A. (1988) Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 85, 3995–3999.
Brüggemann, M., Spicer, C., Buluwela, L., Rosewell, I., Barton, S., Surani, M. A., and Rabbitts, T. H. (1991) Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus. Eur. J. Immunol. 21, 1323–1326.
Lonberg, N., Taylor, L. D., Harding, F. A., Trounstine, M., Higgins, K. M., Schramm, S. R., Kuo, C. C., Mashayekh, R., Wymore, K., McCabe, J. G., and et al. (1994) Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368, 856–859.
Lonberg, N., and Huszar, D. (1995) Human antibodies from transgenic mice. Int. Rev. Immunol. 13, 65–93.
Jakobovits, A. (1995) Production of fully human antibodies by transgenic mice. Curr. Opin. Biotechnol. 6, 561–566.
Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., and Winter, G. (1991) By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222, 581–597.
Welschof, M., Terness, P., Kolbinger, F., Zewe, M., Dübel, S., Dörsam, H., Hain, C., Finger, M., Jung, M., Moldenhauer, G., Hayashi, N., Little, M., and Opelz, G. (1995) Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. J. Immunol. Methods 179, 203–214.
Lagerkvist, A. C., Furebring, C., and Borrebaeck, C. A. (1995) Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning. Biotechniques 18, 862–869.
Terness, P., Welschof, M., Moldenhauer, G., Jung, M., Moroder, L., Kirchhoff, F., Kipriyanov, S., Little, M., and Opelz, G. (1997) Idiotypic vaccine for treatment of human B-cell lymphoma. Construction of IgG variable regions from single malignant B cells. Hum. Immunol. 56, 17–27.
Liu, A. Y., Robinson, R. R., Hellström, K. E., Murray, E. D., Chang, C. P., and Hellström, I. (1987) Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc. Natl. Acad. Sci. USA 84, 3439–3443.
Padlan, E. A. (1994) Anatomy of the antibody molecule. Mol. Immunol. 31, 169–217.
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., and Winter, G. (1986) Replacing the complementarity-determing regions in a human antibody with those from a mouse. Nature 321, 522–525.
Verhoeyen, M., Milstein, C., and Winter, G. (1988) Reshaping human antibodies: grafting an antilysozyme activity. Science 239, 1534–1536.
Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., and Waldmann, T. A. (1989) A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 86, 10,029–10,033.
Co, M. S., and Queen, C. (1991) Humanized antibodies for therapy. Nature 351, 501,502.
Ohtomo, T., Tsuchiya, M., Sato, K., Shimizu, K., Moriuchi, S., Miyao, Y., Akimoto, T., Akamatsu, K., Hayakawa, T., and Ohsugi, Y. (1995) Humanization of mouse ONS-M21 antibody with the aid of hybrid variable regions. Mol. Immunol. 32, 407–416.
Kolbinger, F., Saldanha, J., Hardman, N., and Bendig, M. M. (1993) Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Protein Eng. 6, 971–980.
Roguska, M. A., Pedersen, J. T., Henry, A. H., Searle, S. M., Roja, C. M., Avery, B., Hoffee, M., Cook, S., Lambert, J. M., Blattler, W. A., Rees, A. R., and Guild, B. C. (1996) A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing. Protein Eng. 9, 895–904.
Kettleborough, C. A., Saldanha, J., Heath, V. J., Morrison, C. J., and Bendig, M. M. (1991) Humanization of a mouse monoclonal antibody of CDR-grafting: the importance of framework residues on loop conformation. Protein Eng. 4, 773–783.
Mateo, C., Moreno, E., Amour, K., Lombardero, J., Harris, W., and Perez, R. (1997) Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology 3, 71–81.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., and Shepard, H. M. (1992) Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 89, 4285–4289.
Kashmiri, S. V., Shu, L., Padlan, E. A., Milenic, D. E., Schlom, J., and Hand, P. H. (1995) Generation, characterization, and in vivo studies of humanized anti-carcinoma antibody CC49. Hybridoma 14, 461–473.
Shalaby, M. R., Shepard, H. M., Presta, L., Rodrigues, M. L., Beverley, P. C., Feldmann, M., and Carter, P. (1992) Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. J. Exp. Med. 175, 217–225.
Rodrigues, M. L., Shalaby, M. R., Werther, W., Presta, L., and Carter, P. (1992) Engineering a humanized bispecific F(ab’)2 fragment for improved binding to T cells. Int. J. Cancer (Suppl.) 7, 45–50.
Adair, J. R., Athwal, D. S., Bodmer, M., Bright, S. M., Collins, A., Pulito, V. L., Rao, P. E., Reedman, R., Rothermel, A. L., Xu, D., Zivin, R. A., and Jolliffe, L. K. (1994) Humanization of the murine anti-human CD3 monoclonal antibody OKT3. Hum. Antibod. Hybridomas 5, 41–47.
Pulito, V. L., Roberts, V. A., Adair, J. R., Rothermel, A. L., Collins, A. M., Varga, S. S., Martocello, C., Bodmer, M. W., Jolliffe, L. K., and Zivin, R. A. (1996) Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. J. Immunol. 156, 2840–2850.
Hsiao, K.-C., Bajorath, J., and Harris, L. J. (1994) Humanization of 60.3, an anti-CD18 antibody; importance of the L2 loop. Protein Eng. 7, 815–822.
Leung, S.-O., Goldenberg, D. M., Dion, A., Pellegrini, M. C., Shevitz, J., Shih, L. B., and Hansen, H. J. (1995) Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2. Mol. Immunol. 32, 1413–1427.
Graziano, R. F., Tempest, P. R., White, P., Keler, T., Deo, Y., Ghebremariam, H., Coleman, K., Pfefferkorn, L. C., Fanger, M. W., and Guyre, P. M. (1995) Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody. J. Immunol. 155, 4996–5002.
Riechmann, L., Clark, M., Waldmann, H., and Winter, G. (1988) Reshaping human antibodies for therapy. Nature 332, 323–327.
Tempest, P. R., Bremner, P., Lambert, M., Taylor, G., Furze, J. M., Carr, F. J., and Harris, W. J. (1991) Reshaping a human monoclonal antibody to inhibit human respiratory syncytical virus infection in vivo. Biol Technology 9, 266–271.
Padlan, E. A. (1991) A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties. Mol. Immunol. 28, 489–498.
Pedersen, J. T., Henry, A. H., Searle, S. J., Guild, B. C., Roguska, M., and Rees, A. R. (1994) Comparison of surface accessible residues in human and murine immunoglobulin Fv domains. Implication for humanization of murine antibodies. J. Mol. Biol. 235, 959–973.
Mark, G. E., and Padlan, E. A. (1994) Humanization of monoclonal antibodies, in Handbook of Experimental Pharmacology, Vol. 113: The Pharmacology of Monoclonal Antibodies (Rosenberg, M., and Moore, G. P., eds.), Springer-Verlag, Berlin, Heidelberg, pp. 105–134.
Roguska, M. A., Pedersen, J. T., Keddy, C. A., Henry, A. H., Searle, S. J., Lambert, J. M., Goldmacher, V. S., Blattler, W. A., Rees, A. R., and Guild, B. C. (1994) Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc. Natl. Acad. Sci. USA 91, 969–973.
Woodle, E. S., Thistlethwaite, J. R., Jolliffe, L. K., Zivin, R. A., Collins, A., Adair, J. R., Bodmer, M., Athwal, D., Alegre, M.-L., and Bluestone, J. A. (1992) Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J. Immunol. 148, 2756–2763.
Alegre, M.-L., Collins, A., Pulito, V. L., Brosius, R. A., Olson, W. C., Zivin, R. A., Knowles, R., Thistlethwaite, J. R., Jolliffe, L. K., and Bluestone, J. A. (1992) Effect of a single amino acid mutation on the activating and immunosuppressive properties of a “humanized” OKT3 monoclonal antibody. J. Immunol. 148, 3461–3468.
Alegre, M.-L., Peterson, L. J., Xu, D., Sattar, H. A., Jeyarajah, D. R., Knowlakowski, K., Thistlethwaite, J. R., Zivin, R. A., Jolliffe, L. K., and Bluestone, J. A. (1994) A non-activating “humanized” anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation 57, 1537–1543.
Sun, L. K., Curtis, P., Rakowicz-Szulczynska, E., Ghrayeb, J., Chang, N., Morrison, S. L., and Koprowski, H. (1987) Chimeric antibody with human constant regions and mouse variable regins directed against carcinoma-associated antigen 17-1A. Proc. Natl. Acad. Sci. USA 84, 214–218.
Bebbington, C. R., Renner, G., Thomspon, S., King, D., Abrams, D., and Yarranton, G. T. (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio/Technology 10, 169–175.
Page, M. J., and Sydenham, M. A. (1991) High level expression of the humanized monoclonal antibody CAMPATH-1H in Chinese hamster ovary cells. Bio/Technology 9, 64–68.
Fouser, L. A., Swanberg, S. L., Lin, B.-Y., Benedict, M., Kelleher, K., Cumming, D. A., and Riedel, G. E. (1992) High level expression of a chimeric anti-ganglioside GD2 antibody: genomic kappa sequences improve expression in COS and CHO cells. Bio/Technology 10, 1121–1127.
Dorai, H., and Moore, G. P. (1987) The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes. J. Immunol. 139, 4232–4241.
Shitara, K., Nakamura, K., Tokutake-Tanaka, Y., Fukushima, M., and Hanai, N. (1994) A new vector for the high level expression of chimeric antibodies in myeloma cells. J. Immunol. Methods 167, 271–278.
Shu, L., Qi, C.-F., Schlom, J., and Kashmiri, S. V. S. (1993) Secretion of a single-gene-encoded immunoglobulin from myeloma cells. Proc. Natl. Acad. Sci. USA 90, 7995–7999.
Smith, J. W., Hu, D., Satterthwait, A., Pinzsweeney, S., and Barbas, C. F. (1994) Building synthetic anti-bidies as adhesive ligands for integrins. J. Biol. Chem. 269, 32,788–32,795.
Traunecker, A., Lanzavecchia, A., and Karjalainen, K. (1991) Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. EMBO J. 10, 3655–3659.
Traunecker, A., Lanzavecchia, A., and Karjalainen, K. (1992) Janusin: new molecular design for bispecific reagents. Int. J. Cancer (Suppl.) 7, 51,52.
Chamow, S. M., Zhang, D. Z., Tan, X. Y., Mhatre, S. M., Marsters, S. A., Peers, D. H., Byrn, R. A., Ashkenazi, A., and Junghans, R. P. (1994) A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. J. Immunol. 153, 4268–4280.
Ridgway, J. B., Presta, L. G., and Carter, P. (1996) ‚Knobs-into-holes‘ engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 9, 617–621.
De Sutter, K., Feys, V., Van de Voorde, A., and Fiers, W. (1992) Production of functionally active murine and murine::human chimeric F(ab’)2 fragments in COS-1 cells. Gene 113, 223–230.
Young, R. J., Owens, R. J., Mackay, G. A., Chan, C. M. W., Shi, J., Hide, M., Francis, D. M., Henry, A. J., Sutton, B. J., and Gould, H. J. (1995) Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosilation site mutants. Protein Eng. 8, 193–199.
King, D. J., Byron, O. D., Mountain, A., Weir, N., Harvey, A., Lawson, A. D. G., Proudfoot, K. A., Baldock, D., Harding, S. E., Yarranton, G. T., and Owens, R. J. (1993) Expression, purification and characterization of B72.3 Fv fragments. Biochem. J. 290, 723–729.
Jost, C. R., Kurucz, I., Jacobus, C. M., Titus, J. A., George, A. J., and Segal, D. M. (1994) Mammalian expression and secretion of functional single-chain Fv molecules. J. Biol. Chem. 269, 26,267–26,273.
Hu, S., Shively, L., Raubitschek, A., Sherman, M., Williams, L. E., Wong, J. Y., Shively, J. E., and Wu, A. M. (1996) Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 56, 3055–3061.
Libyh, M. T., Goossens, D., Oudin, S., Gupta, N., Dervillez, X., Juszczak, G., Cornillet, P., Bougy, F., Reveil, B., Philbert, F., Tabary, T., Klatzmann, D., Rouger, P., and Cohen, J. H. (1997) A recombinant human scFv anti-Rh(D) antibody with multiple valences using a C-terminal fragment of C4-binding protein. Blood 90, 3978–3983.
Gillies, S. D., Lan, Y., Wesolowski, J. S., Qian, X., Reisfeld, R. A., Holden, S., Super, M., and Lo, K.-M. (1998) Antibody-IL-12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma matastases. J. Immunol. 160, 6195–6203.
Dorai, H., McCartney, J. E., Hudziak, R. M., Tai, M.-S., Laminet, A. A., Houston, L. L., Huston, J. S., and Oppermann, H. (1994) Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains. Bio/Technology 12, 890–897.
Jost, C. R., Titus, J. A., Kurucz, I., and Segal, D. M. (1996) A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL. Mol. Immunol. 33, 211–219.
Mack, M., Riethmüller, G., and Kufer, P. (1995) A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 7021–7025.
Limonta, J., Pedraza, A., Rodriguez, A., Freyre, F. M., Barral, A. M., Castro, F. O., Lleonart, R., Gracia, C. A., Gavilondo, J. V., and de la Fuente, J. (1995) Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice. Immunotechnology 1, 107–113.
Richardson, J. H., Sodroski, J. G., Waldmann, T. A., and Marasco, W. A. (1995) Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the a subunit of the receptor. Proc. Natl. Acad. Sci. USA 92, 3137–3141.
Biocca, S., Pierandrei-Amaldi, P., Campioni, N., and Cattaneo, A. (1994) Intracellular immunization with cytosolic recombinant antibodies. Bio/Technology 12, 396–399.
Biocca, S., Ruberti, F., Tafani, M., Pierandrei-Amaldi, P., and Cattaneo, A. (1995) Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria. Bio/Technology 13, 1110–1115.
Jiang, W., Venugopal, K., and Gould, E. A. (1995) Intracellular interference of tick-borne flavivirus infection by using a single-chain antibody fragment delivered by recombinant Sindbis virus. J. Virol. 69, 1044–1049.
Levin, R., Mhashilkar, A. M., Dorfman, T., Bukovsky, A., Zani, C., Bagley, J., Hinkula, J., Niedrig, M., Albert, J., Wahren, B., Gottlinger, H. G., and Marasco, W. A. (1997) Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol. Med. 3, 96–110.
Mhashilkar, A. M., Biswas, D. K., LaVecchio, J., Pardee, A. B., and Marasco, W. A. (1997) Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. J. Virol. 71, 6486–6494.
Rode, H.-J., Little, M., Fuchs, P., Dorsam, H., Schooltink, H., de Ines, C., Dubel, S., and Breitling, F. (1996) Cell surface display of a single-chain antibody for attaching polypeptides. Biotechniques 21, 650–658.
Eshhar, Z., Bach, N., Fitzer Attas, C. J., Gross, G., Lustgarten, J., Waks, T., and Schindler, D. G. (1996) The T-body approach: potential for cancer immunotherapy. Springer Semin. Immunopathol. 18, 199–209.
Eshhar, Z. (1997) Tumor-specific T-bodies: towards clinical application. Cancer Immunol. Immunother. 45, 131–136.
Eshhar, Z., Waks, T., Gross, G., and Schindler, D. G. (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. USA 90, 720–724.
Hwu, P., Shafer, G. E., Treisman, J., Schindler, D. G., Gross, G., Cowherd, R., Rosenberg, S. A., and Eshhar, Z. (1993) Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J. Exp. Med. 178, 361–366.
Poul, M.-A., Cerutti, M., Chaabihi, H., Ticchioni, M., Deramoudt, F.-X., Bernard, A., Devauchelle, G., Kaczorek, M., and Lefranc, M.-P. (1995) Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells. Eur. J. Immunol. 25, 2005–2009.
Kretzschmar, T., Aoustin, L., Zingel, O., Marangi, M., Vonach, B., Towbin, H., and Geiser, M. (1996) High-level expression in insect cells and purification of secreted monomeric single-chain Fv antibodies. J. Immunol. Methods 195, 93–101.
Brocks, B., Rode, H.-J., Klein, M., Gerlach, E., Dübel, S., Little, M., Pfitzenmaier, K., and Moosmayer, D. (1997) A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono-and bivalent scFv derivative in insect cells. Immunotechnology 3, 173–184.
Ma, J. K., Hiatt, A., Hein, M., Vine, N. D., Wang, F., Stabila, P., van Dolleweerd, C., Mostov, K., and Lehner, T. (1995) Generation and assembly of secretory antibodies in plants. Science 268, 716–719.
Ma, J. K., and Hein, M. B. (1995) Immunotherapeutic potential of antibodies produced in plants. Trends Biotechnol. 13, 522–527.
Hiatt, A. C., Cafferkey, R., and Bowdish, K. (1989) Production of antibodies in transgenic plants. Nature 342, 76–78.
During, K., Hippe, S., Kreuzaler, E., and Schell, J. (1990) Synthesis and self-assembly of a functional antibody in transgenic Nicotiana tabacum. Plant Mol. Biol. 15, 281–293.
Tavladoraki, P., Benvenuto, E., Trinca, S., De Martinis, D., Cattaneo, A., and Galeffi, P. (1993) Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366, 469–472.
Fiedler, U., and Conrad, U. (1995) High-level production and long-term storage of engineered antibodies in transgenic tabacco seeds. Bio/Technology 13, 1090–1093.
Wood, C. R., Boss, M. A., Kenten, J. H., Calvert, J. E., Roberts, N. A., and Emtage, J. S. (1985) The synthesis and in vivo assembly of functional antibodies in yeast. Nature 314, 446–449.
Horwitz, A. H., Chang, C. P., Better, M., Hellstrom, K. E., and Robinson, R. R. (1988) Secretion of functional antibody and Fab fragment from yeast cells. Proc. Natl. Acad. Sci. USA 85, 8678–8682.
Boder, E. T., and Wittrup, K. D. (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nature Biotechnol. 15, 553–557.
Cregg, J. M., Vedvick, T. S., and Raschke, W. C. (1993) Recent advances in the expression of foreign genes in Pichia pastoris. Bio/Technology 11, 905–910.
Hollenberg, C. P., and Gelissen, G. (1997) Production of recombinant proteins by methylotrophic yeasts. Curr. Opin. Biotechnol. 8, 554–560.
Ridder, R., Schmitz, R., Legay, F., and Gram, H. (1995) Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Bio/Technology 13, 255–260.
Eldin, P., Pauza, M. E., Hieda, Y., Lin, G., Murtaugh, M. P., Pentel, P. R., and Pennell, C. A. (1997) High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J. Immunol. Methods 201, 67–75.
FitzGerald, K., Holliger, P., and Winter, G. (1997) Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris. Protein Eng. 10, 1221–1225.
Nyyssönen, E., Penttilä, M., Harkki, A., Saloheimo, A., Knowles, J. K. C., and Keränen, S. (1993) Efficient production of antibody fragments by the filamentous fungus Trichoderma reesei. Bio/Technology 11, 591–595.
Boss, M. A., Kenten, J. H., Wood, C. R., and Emtage, J. S. (1984) Assembly of functional antibodies from immunoglobulin heavy and light chains synthesized in E. coli. Nucl. Acids Res. 12, 3791–3806.
Wu, X.-C., Ng, S.-C., Near, R. I., and Wong, S.-L. (1993) Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system. Bio/Technology 11, 71–76.
Better, M., Cheng, C. P., Robinson, R. R., and Horowitz, A. H. (1988) E. coli secretion of an active chimeric antibody fragment. Science 240, 1041–1043.
Skerra, A., and Pluckthun, A. (1988) Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240, 1038–1041.
Fuchs, P., Dübel, S., Breitling, F., Braunagel, M., Klewinghaus, I., and Little, M. (1992) Recombinant human monoclonal antibodies. Basic principles of the immune system transferred to E. coli. Cell Biophys. 21, 81–91.
Ward, E. S., Güssow, D., Griffiths, A. D., Jones, P. T., and Winter, G. (1989) Binding activities of a repertoire of single immunoglobulin variable domains secreted from E. coli. Nature 341, 544–546.
Huse, W. D., Sastry, L., Iverson, S. A., Kang, A. S., Alting-Mees, M., Burton, D. R., Benkovic, S. J., and Lerner, R. A. (1989) Generation of a large combinatorial library of the immunoglobin repertoire in phage lambda. Science 246, 1275–1281.
Caton, A. J., and Koprowski, H. (1990) Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor. Proc. Natl. Acad. Sci. USA 87, 6450–6454.
Mullinax, R. L., Gross, E. A., Amberg, J. R., Hay, B. N., Hogrefe, H. H., Kubitz, M. M., Greener, A., Alting-Mees, M., Ardourel, D., Short, J. M., Sorge, J. A., and Shopes, B. (1990) Identification of human antibody clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library. Proc. Natl. Acad. Sci. USA 87, 8095–8099.
Russel, S. J., Hawkins, R. E., and Winter, G. (1993) Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21, 1081–1085.
Boublik, Y., Di Bonito, P., and Jones, I. M. (1995) Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Bio/Technology 13, 1079–1084.
Kieke, M. C., Cho, B. K., Boder, E. T., Kranz, D. M., and Wittrup, K. D. (1997) Isolation of anti-T cell receptor scFv mutants by yeast surface display. Protein Eng. 10, 1303–1310.
Mattheakis, L. C., Bhatt, R. R., and Dower, W. J. (1994) An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. USA 91, 9022–9026.
Hanes, J., and Plückthun, A. (1997) In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. USA 94, 4937–4942.
He, M., and Taussig, M. J. (1997) Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucl. Acids Res. 25, 5132–5134.
Smith, G. P., and Petrenko, V. A. (1997) Phage display. Chem. Rev. 97, 391–410.
Webster, R. E., and Lopez, J. (1985) Structure and assembly of the class I filamentous bacteriophage, in Virus Structure and Assembly (Casjens, S., eds.), Jones and Bartlett Inc., Boston/Portala Valley, USA, pp. 235–267.
Smith, G. P. (1988) Filamentous phages as cloning vectors, in: Vectors (Rodriguez, R. L., and Denhardt, D. T., eds.), Butterworths, Boston, MA, pp. 61–83.
Riechmann, L., and Holliger, P. (1997) The C-terminal domain of TolA is the coreceptor for filamentous phage infection of E. coli. Cell 90, 351–360.
Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315–1317.
Parmley, S. F., and Smith, G. P. (1988) Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73, 305–318.
Scott, J. K., and Smith, G. P. (1990) Searching for peptide ligands with an epitope library. Science 249, 386–390.
Devlin, J. J., Panganiban, L. C., and Devlin, P. E. (1990) Random peptide libraries: a source of specific protein binding molecules. Science 249, 404–406.
Cwirla, S. E., Peters, E. A., Barrett, R. W., and Dower, W. J. (1990) Peptides on phage: A vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87, 6378–6382.
McCafferty, J., Griffiths, A. D., Winter, G., and Chiswell, D. J. (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552–554.
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P., and Winter, G. (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl. Acids Res. 19, 4133–4137.
Breitling, F., Dübel, S., Seehaus, T., Klewinghaus, I., and Little, M. (1991) A surface expression vector for antibody screening. Gene 104, 147–153.
Barbas, C. F., Kang, A. S., Lerner, R. A., and Benkovic, S. J. (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA 88, 7978–7982.
Ørum, H., Andersen, P. S., Øster, A., Johansen, L. K., Riise, E., Bjørnvad, M., Svendsen, I., and Engberg, J. (1993) Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage. Nucl. Acids Res. 21, 4491–4498.
Ward, R. L., Clark, M. A., Lees, J., and Hawkins, N. J. (1996) Retrieval of human antibodies from phagedisplay libraries using enzymatic cleavage. J. Immunol. Methods 189, 73–82.
Meulemans, E. V., Slobbe, R., Wasterval, P., Ramaekers, F. C. S., and Van Eys, G. J. J. M. (1994) Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody. J. Mol. Biol. 244, 353–360.
Dübel, S., Breitling, F., Klewinghaus, I., and Little, M. (1992) Regulated secretion and purification of recombinant antibodies in E. coli. Cell Biophys. 21, 69–79.
Hayashi, N., Kipriyanov, S., Fuchs, P., Welschof, M., Dörsam, H., and Little, M. (1995) A single expression system for the display, purification and conjugation of single-chain antibodies. Gene 160, 129–130.
Waterhouse, P., Griffiths, A., Johnson, K. S., and Winter, G. (1993) Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires. Nucl. Acids Res. 21, 2265–2266.
Geoffroy, F., Sodoyer, R., and Aujame, L. (1994) A new phage display system to construct multicombinatorial libraries of very large antibody repertoires. Gene 151, 109–113.
Little, M., Fuchs, P., Breitling, F., and Dübel, S. (1993) Bacterial surface presentation of proteins and peptides: an alternative to phage technology? Trends Biotechnol. 11, 3–5.
Duenas, M., and Borrebaeck, C. A. (1994) Clonal selection and amplification of phage displayed antibodies by linking antigen recognition and phage replication. Bio/Technology 12, 999–1002.
Krebber, C., Spada, S., Desplancq, D., and Plückthun, A. (1995) Co-selection of cognate antibody-antigen pairs by selectively-infective phages. FEBS Lett. 377, 227–231.
Krebber, C., Spada, S., Desplancq, D., Krebber, A., Ge, L., and Plückthun, A. (1997) Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactions. J. Mol. Biol. 268, 607–618.
Rondot, S., Anthony, K., Dübel, S., Ida, N., Beyreuther, K., Frost, L., Little, M., and Breitling, F. (1998) Epitopes fused to F-pilin are incorporated into functional recombinant pili. J. Mol. Biol. 279, 589–603.
Malmborg, A. C., Söderlind, E., Frost, L., and Borrebaeck, C. A. (1997) Selective phage infection mediated by epitope expression on F pilus. J. Mol. Biol. 273, 544–551.
Bass, S., Greene, R., and Wells, J. A. (1990) Hormone phage: an enrichment method for variant proteins with altered binding properties. Proteins 8, 309–314.
Kuhn, A., and Wickner, W. (1985) Isolation of mutants in M13 coat protein that affect its synthesis, processing and assembly into phage. J. Biol. Chem. 260, 15,907–15,913.
Felici, F., Castagnoli, L., Musacchio, A., Jappelli, R., and Cesareni, G. (1991) Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J. Mol. Biol. 222, 301–310.
Ilyichev, A. A., Minenkova, O. O., Kishchenko, G. P., Tat’kov, S. I., Karpishev, N. N., Eroshkin, A. M., Ofitzerov, V. I., Akimenko, Z. A., Petrenko, V. A., and Sandakhchiev, L. S. (1992) Inserting foreign peptides into the major coat protein of bacteriophage M13. FEBS Lett. 301, 322–324.
Kang, A. S., Barbas, C. F., Janda, K. D., Benkovic, S. J., and Lerner, R. A. (1991) Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc. Natl. Acad. Sci. USA 88, 4363–4366.
Huse, W. D., Stinchcombe, T. J., Glaser, S. M., Starr, L., MacLean, M., Hellström, K. E., Hellström, I., and Yelton, D. E. (1992) Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F(ab’) antibody fragments. J. Immunol. 149, 3914–3920.
Gram, H., Marconi, L. A., Barbas, C. F., Collet, T. A., Lerner, R. A., and Kang, A. S. (1992) In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc. Natl. Acad. Sci. USA 89, 3576–3580.
Kretzschmar, T., and Geiser, M. (1995) Evaluation of antibodies fused to minor coat protein III and major coat protein VIII of bacteriophage M13. Gene 155, 61–65.
Simons, G. F. M., Konings, R. N. H., and Schoenmakers, J. G. G. (1981) Genes VI, VII and IX of phage M13 code for minor capsid proteins of the virion. Proc. Natl. Acad. Sci. USA 78, 4194–4198.
Makowski, L. (1992) Terminating a macromolecular helix: structural model for the minor proteins of bacteriophage M13. J. Mol. Biol. 228, 885–892.
Jespers, L. S., Messens, J. H., De Keyser, A., Eeckhout, D., Van Den Brande, I., Gansemans, Y. G., Lauwereys, M. J., Vlasuk, G. P., and Stanssens, E. (1995) Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI. Bio/Technology 13, 378–382.
Hogrefe, H. H., Mullinax, R. L., Lovejoy, A. E., Hay, B. N., and Sorge, J. A. (1993) A bacteriophage lambda vector for the cloning and expression of immunoglobulin Fab fragments on the surface of filamentous phage. Gene 128, 119–126.
Brinkmann, U., Chowdhury, P. S., Roscoe, D. M., and Pastan, I. (1995) Phage display of disulfide-stabilized Fv fragments. J. Immunol. Methods 182, 41–50.
McGuinness, B. T., Walter, G., FitzGerald, K., Schuler, P., Mahoney, W., Duncan, A. R., and Hoogenboom, H. R. (1996) Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nature Biotechnol. 14, 1149–1154.
Söderlind, E., Lagerkvist, A. C. S., Duenas, M., Malmborg, A.-C., Ayala, M., Danielsson, L., and Borrebaeck, C. A. K. (1993) Chaperonin assisted phage display of antibody fragments on filamentous bacteriophages. Bio/Technology 11, 503–507.
Bothmann, H., and Plückthun, A. (1998) Selection for a periplasmic factor improving phage display and functional periplasmic expression. Nature Biotechnol. 16, 376–380.
Fuchs, P., Breitling, F., Dübel, S., Seehaus, T., and Little, M. (1991) Targeting recombinant antibodies to the surface of Escherichia coli: fusion to a peptidoglycan associated lipoprotein. Bio/Technology 9, 1369–1372.
Fuchs, P., Weichel, W., Dübel, S., Breitling, F., and Little, M. (1996) Separation of E. coli expressing functional cell-wall bound antibody fragments by FACS. Immunotechnology 2, 97–102.
Francisco, J. A., Campbell, R., Iverson, B. L., and Georgiou, G. (1993) Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. Proc. Natl. Acad. Sci. USA 90, 10,444–10,448.
Lu, Z., Murray, K. S., Van Cleave, V., LaVallie, E. R., Stahl, M., and McCoy, J. M. (1995) Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Bio/Technology 13, 366–372.
Bradbury, A., Persic, L., Werge, T., and Cattaneo, A. (1993) Use of living columns to select specific phage antibodies. Bio/Technology 11, 1565–1569.
Davies, E. L., Smith, J. S., Birkett, C. R., Manser, J. M., Anderson-Dear, D. V., and Young, J. R. (1995) Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes. J. Immunol. Methods 186, 125–135.
Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., and Muyldermans, S. (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414, 521–526.
Orlandi, R., Gussow, D. H., Jones, P. T., and Winter, G. (1989) Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86, 3833–3837.
Persson, M. A. A., Caothien, R. H., and Burton, D. R. (1991) Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl. Acad. Sci. USA 88, 2432–2436.
Chester, K. A., Begent, R. H. J., Robson, L., Keep, P., Pedley, R. B., Boden, J. A., Boxer, G., Green, A., Winter, G., Cochet, O., and Hawkins, R. E. (1994) Phage libraries for generation of clinically useful antibodies. Lancet 343, 455,456.
Amas, R. S., Tornetta, M. A., Jones, C. S., and Tsui, P. (1994) Isolation of neutralizing anti-C5a monoclonal antibodies from a filamentous phage monovalent Fab display library. J. Immunol. 152, 4572–4581.
Burton, D. R., Barbas, C. F. d., Persson, M. A., Koenig, S., Chanock, R. M., and Lerner, R. A. (1991) A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88, 10,134–10,137.
Barbas, C. F., Bjorling, E., Chiodi, F., Dunlop, N., Cababa, D., Jones, T. M., Zebedee, S. L., Persson, M. A., Nara, P. L., Norrby, E., and Burton, D. R. (1992) Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 89, 9339–9343.
Barbas, C. F., Collet, T. A., Amberg, W., Roben, P., Binley, J. M., Hoekstra, D., Cababa, D., Jones, T. M., Williamson, R. A., Pilkington, G. R., Haigwood, N. L., Cabezas, E., Satterthwait, A. C., Sanz, I., and Burton, D. R. (1993) Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230, 812–823.
Barbas, C. F., Crowe, J. E., Cababa, D., Jones, T. M., Zebedee, S. L., Murphy, B. R., Chanock, R. M., and Burton, D. R. (1992) Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc. Natl. Acad. Sci. USA 89, 10,164–10,168.
Zebedee, S. L., Barbas, C. F., Hom, Y. L., Caothien, R. H., Graff, R., DeGraw, J., Pyati, J., LaPolla, R., Burton, D. R., Lerner, R. A., and Thornton, G. B. (1992) Human combinatorial antibody libraries to hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 89, 3175–3179.
Williamson, R. A., Burioni, R., Sanna, P. P., Partridge, L. J., Barbas, C. F., and Burton, D. R. (1993) Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc. Natl. Acad. Sci. USA 90, 4141–4145.
Welschof, M., Terness, P., Kipriyanov, S. M., Stanescu, D., Breitling, F., Dörsam, H., Dübel, S., Little, M., and Opelz, G. (1997) The antigen-binding domain of a human IgG-anti-F(ab’)2 autoantibody. Proc. Natl. Acad. Sci. USA 94, 1902–1907.
Ditzel, H. J., Binley, J. M., Moore, J. P., Sodroski, J., Sullivan, N., Sawyer, L. S. W., Hendry, R. M., Yang, W. P., Barbas, C. F., and Burton, D. R. (1995) Neurtralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp 120 isolated by using an epitope-masking procedure. J. Immunol. 154, 893–906.
Little, M., Breitling, F., Dübel, S., Fuchs, P., Braunagel, M., Seehaus, T., and Klewinghaus, I. (1993) Universal antibody libraries on phage and bacteria, in Year Immunol., Vol. 7: Generation of antibodies by cell and gene immortalization (Terhorst, C., Malavasi, F., and Albertini, A., eds.), Karger, Basel, pp. 50–55.
Little, M., Breitling, F., Dubel, S., Fuchs, P., and Braunagel, M. (1995) Human antibody libraries in Escherichia coli. J. Biotechnol. 41, 187–195.
Dörsam, H., Rohrbach, P., Kürschner, T., Kipriyanov, S., Renner, S., Braunagel, M., Welschof, M., and Little, M. (1997) Antibodies to steroids from a small human naive IgM library. FEBS Lett. 414, 7–13.
Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., Baier, M., Holliger, K. P., Gorick, B. D., Hughes-Jones, N. C., Hoogenboom, H. R., and Winter, G. (1993) Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12, 725–734.
Schier, R., Marks, J. D., Wolf, E. J., Apell, G., Wong, C., McCartney, J. E., Bookman, M. A., Huston, J. S., Houston, L. L., Weiner, L. M., and Adams, G. P. (1995) In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library. Immunotechnology 1, 73–81.
Low, N. M., Holliger, P., and Winter, G. (1996) Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. J. Mol. Biol. 260, 359–368.
Hawkins, R. E., Russell, S. J., and G., W. (1992) Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226, 889–896.
Riechmann, L., and Weill, M. (1993) Phage display and selection of a site-directed randomized single-chain antibody Fv fragment for its affinity improvement. Biochemistry 32, 8848–8855.
Balint, R. F., and Larrick, J. W. (1993) Antibody engineering by parsimonious mutagenesis. Gene 137, 109–118.
Barbas, C. F., Hu, D., Dunlop, N., Sawyer, L., Cababa, D., Hendry, R. M., Nara, P. L., and Burton, D. R. (1994) In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc. Natl. Acad. Sci. USA 91, 3809–3813.
Yang, W.-P., Green, K., Pinz-Sweeney, S., Briones, A. T., Burton, D. R., and Barbas, C. F. (1995) CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J. Mol. Biol. 254, 392–403.
Schier, R., McCall, A., Adams, G. P., Marshall, K. W., Merritt, H., Yim, M., Crawford, R. S., Weiner, L. M., Marks, C., and Marks, J. D. (1996) Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J. Mol. Biol. 263, 551–567.
Marks, J. D., Hoogenboom, H. R., Griffiths, A. D., and Winter, G. (1992) Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system. J. Biol. Chem. 267, 16,007–16,010.
Schier, R., Bye, J., Apell, G., McCall, A., Adams, G. P., Malmqvist, M., Weiner, L. M., and Marks, J. D. (1996) Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J. Mol. Biol. 255, 28–43.
Thompson, J., Pope, T., Tung, J.-S., Chan, C., Hollis, G., Mark, G., and Johnson, K. S. (1996) Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J. Mol. Biol. 256, 77–88.
Jespers, L. S., Roberts, A., Mahler, S. M., Winter, G., and Hoogenboom, H. R. (1994) Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biol Technology 12, 899–903.
Ohlin, M., Owman, H., Mach, M., and Borrebaeck, C. A. (1996) Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. Mol. Immunol. 33, 47–56.
Kussie, P. H., Parhami-Seren, B., Wysocki, L. J., and Margolies, M. N. (1994) A single engineered amino acid substitution changes antibody fine specificity. J. Immunol. 152, 146–152.
Ward, E. S. (1995) VH shuffling can be used to convert an Fv fragment of anti-hen lysozyme specificity to one that recognizes a T cell receptor Va. Mol. Immunol. 32, 147–156.
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., and Johnson, K. S. (1996) Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnol. 14, 309–314.
Chothia, C., and Lesk, A. M. (1987) Canonical structures for the hypervariable regions of immunoglobulins. J.Mol.Biol. 196, 901–917.
Chothia, C., Lesk, A. M., Tramontano, A., Levitt, M., Smith-Gill, S. J., Air, G., Sheriff, S., Padlan, E. A., Davies, D., Tulip, W. R., Colman, P. M., Spinelli, S., Alzari, P. M., and Poljak, R. J. (1989) Conformations of immunoglobulin hypervariable regions. Nature 342, 877–883.
Chothia, C., Lesk, A. M., Gherardi, E., Tomlinson, I. M., Walter, G., Marks, J. D., Llewelyn, M. B., and Winter, G. (1992) Structural repertoire of the human VH segments. J. Mol. Biol. 227, 799–817.
Vargas-Madrazo, E., Lara-Ochoa, F., and Almagro, J. C. (1995) Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition. J. Mol. Biol. 254, 497–504.
Barbas, C. F., Bain, J. D., Hoekstra, D. M., and Lerner, R. A. (1992) Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc. Natl. Acad. Sci. USA 89, 4457–4461.
Braunagel, M., and Little, M. (1997) Construction of a semisynthetic antibody library using trinucleotide oligos. Nucl. Acids Res. 25, 4690–4691.
Barbas, C. F., Languino, L. R., and Smith, J. W. (1993) High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc. Natl. Acad. Sci. USA 90, 10,003–10,007.
Barbas, C. F., Amberg, W., Simoncsits, A., Jones, T. M., and Lerner, R. A. (1993) Selection of human antihapten antibodies from semisynthetic libraries. Gene 137, 57–62.
Barbas, C. F., Rosenblum, J. S., and Lerner, R. A. (1993) Direct selection of antibodies that coordinate metals from semisynthetic combinatorial libraries. Proc. Natl. Acad. Sci. USA 90, 6385–6389.
Janda, K. D., Lo, C. L., Li, T., Barbas, C. F., Wirsching, P., and Lerner, R. A. (1994) Direct selection for a catalytic mechanism from combinatorial antibody libraries. Proc. Natl. Acad. Sci. USA 91, 2532–2536.
Hoogenboom, H. R., and Winter, G. (1992) By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol. 227, 381–388.
Akamatsu, Y., Cole, M. S., Tso, J. Y., and Tsurushita, N. (1993) Construction of a human Ig combinatorial library from genomic V segments and synthetic CDR3 fragments. J. Immunol. 151, 4651–4659.
Nissim, A., Hoogenboom, H. R., Tomlinson, I. M., Flynn, G., Midgley, C., Lane, D., and Winter, G. (1994) Antibody fragments from a, single pot’ phage display library as immunochemical reagents. EMBO J. 13, 692–698.
de Kruif, J., Terstappen, L., Boel, E., and Logtenberg, T. (1995) Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc. Natl. Acad. Sci. USA 92, 3938–4392.
de Kruif, J., Boel, E., and Logtenberg, T. (1995) Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J. Mol. Biol. 248, 97–105.
Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., Jones, P. T., Low, N. M., Allison, T. J., Prospero, T. D., Hoogenboom, H. R., Nissim, A., Cox, J. P. L., Harrison, J. L., Zaccolo, M., Gherardi, E., and Winter, G. (1994) Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245–3260.
Garrard, L. J., and Henner, D. J. (1993) Selection of an anti-IGF-1 Fab from a Fab phage library created by mutagenesis of multiple CDR loops. Gene 128, 103–109.
Hayashi, N., Welschof, M., Zewe, M., Braunagel, M., Dübel, S., Breitling, F., and Little, M. (1994) Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR. Biotechniques 17, 310–315.
Virnekäs, B., Ge, L., Plückthun, A., Schneider, K. C., Wellnhofer, G., and Moroney, S. E. (1994) Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucl. Acids Res. 22, 5600–5607.
Huston, J. S., Mudgett Hunter, M., Tai, M. S., McCartney, J., Warren, F., Haber, E., and Oppermann, H. (1991) Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol. 203, 46–88.
Buchner, J., and Rudolph, R. (1991) Renaturation, purification and characterization of recombinant Fabfragments produced in Escherichia coli. Bio/Technology 9, 157–162.
Buchner, J., Pastan, I., and Brinkmann, U. (1992) A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205, 263–270.
Kurucz, I., Titus, J. A., Jost, C. R., and Segal, D. M. (1995) Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies. Mol. Immunol. 32, 1443–1452.
Kurucz, I., Titus, J. A., Jost, C. R., Jacobus, C. M., and Segal, D. M. (1995) Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria. J. Immunol. 154, 4576–4582.
Skerra, A. (1993) Bacterial expression of immunoglobulin fragments. Curr. Opin. Immunol. 5, 256–262.
Brinkmann, U., Buchner, J., and Pastan, I. (1992) Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Proc. Natl. Acad. Sci. USA 89, 3075–3079.
Newton, D. L., Nicholls, P. J., Rybak, S. M., and Youle, R. J. (1994) Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv. J. Biol. Chem. 269, 26,739–26,745.
Newton, D. L., Xue, Y., Olson, K. A., Fett, J. W., and Rybak, S. M. (1996) Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains. Biochemistry 35, 545–553.
Brinkmann, U., Reiter, Y., Jung, S. H., Lee, B., and Pastan, I. (1993) A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc. Natl. Acad. Sci. USA 90, 7538–7542.
Reiter, Y., Brinkmann, U., Jung, S. H., Pastan, I., and Lee, B. (1995) Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation. Protein Eng. 8, 1323–1331.
Webber, K. O., Reiter, Y., Brinkmann, U., Kreitman, R., and Pastan, I. (1995) Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog. Mol. Immunol. 32, 249–258.
Pugsley, A. P. (1993) The complete general secretory pathway in gram-negative bacteria. Microbiol. Rev. 57, 50–108.
Whitlow, M., and Filpula, D. (1991) Single-chain Fv proteins and their fusion proteins. Methods: A Companion to Meth. Enzymol. 2, 97–105.
Kipriyanov, S. M., Dübel, S., Breitling, F., Kontermann, R. E., and Little, M. (1994) Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies. Mol. Immunol. 31, 1047–158.
Hockney, R. C. (1994) Recent developments in heterologous protein production in Escherichia coli. Trends Biotechnol. 12, 456–463.
Plückthun, A. (1994) Antibodies from Escherichia coli, in Handbook of Experimental Pharmacology, Vol. 113: The Pharmacology of Monoclonal Antibodies (Rosenberg, M., and Moore, G. P., eds.), Springer-Verlag, Berlin, Heidelberg, pp. 269–315.
Knappik, A., Krebber, C., and Plückthun, A. (1993) The effect of folding catalysts on the in vivo folding process of different antibody fragments expressed in Escherichia coli. Bio/Technology 11, 77–83.
Duenas, M., Vazquez, J., Ayala, M., Soderlind, E., Ohlin, M., Perez, L., Borrebaeck, C. A., and Gavilondo, J. V. (1994) Intra-and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins. Biotechniques 16, 476–477.
Knappik, A., and Plückthun, A. (1995) Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng. 8, 81–89.
Dill, K. A. (1990) Dominant forces in protein folding. Biochemistry 29, 7133–7155.
Bowden, G. A., and Georgiou, G. (1990) Folding and aggregation of beta-lactamase in the periplasmic space of Escherichia coli. J. Biol. Chem. 265, 16,760–16,766.
Kiefhaber, T., Rudolph, R., Kohler, H. H., and Buchner, J. (1991) Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Bio/Technology 9, 825–829.
Kipriyanov, S. M., Moldenhauer, G., and Little, M. (1997) High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J. Immunol. Methods 200, 69–77.
George, A. J., Titus, J. A., Jost, C. R., Kurucz, I., Perez, P., Andrew, S. M., Nicholls, P. J., Huston, J. S., and Segal, D. M. (1994) Redirection of T cellmediated cytotoxicity by a recombinant single-chain Fv molecule. J. Immunol. 152, 1802–1811.
Kipriyanov, S. M., Dübel, S., Breitling, F., Kontermann, R. E., Heymann, S., and Little, M. (1995) Bacterial expression and refolding of singlechain Fv fragments with C-terminal cysteines. Cell Biophys. 26, 187–204.
Skerra, A., and Pluckthun, A. (1991) Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines. Protein Eng. 4, 971–979.
Takkinen, K., Laukkanen, M.-L., Sizmann, D., Alfthan, K., Immonen, T., Vanne, L., Kaartinen, M., Knowles, J. K. C., and Teeri, T. T. (1991) An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli. Protein Eng. 4, 837–841.
Kipriyanov, S. M., Moldenhauer, G., Martin, A. C., Kupriyanova, O. A., and Little, M. (1997) Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. Protein Eng. 10, 445–453.
Sawyer, J. R., Schlom, J., and Kashmiri, S. V. S. (1994) The effect of induction conditions on production of a soluble anti-tumor sFv in Escherichia coli. Protein Eng. 7, 1401–1406.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kipriyanov, S.M., Little, M. Generation of recombinant antibodies. Mol Biotechnol 12, 173–201 (1999). https://doi.org/10.1385/MB:12:2:173
Issue Date:
DOI: https://doi.org/10.1385/MB:12:2:173